Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06635629 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Desmopressin Stimulation Test Performance in ACTH-Dependent Cushing Syndrome

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Minor 6 versions Re-verified since May 1, 2026, no change to tracked fieldsv41-v46
  2. Minor Study description expanded, about 8 words Eligibility criteria shortened, about 3 wordsv40 Show 1 more changeShow less
    • Eligibility criteria shortened, about 3 words

    See this version in full on ClinicalTrials.gov ↗

  3. Minor 7 versions Re-verified since Mar 26, 2025, no change to tracked fieldsv33-v39
  4. Minor Eligibility criteria expanded, about 108 wordsv32 See this version in full on ClinicalTrials.gov ↗
  5. Minor 2 versions Re-verified since Feb 7, 2025, no change to tracked fieldsv30-v31
Show 28 earlier versionsHide 28 earlier versions
  1. Minor Start date changed from estimate of Dec 22, 2024 to Dec 12, 2024v29
  2. Minor Start date: Dec 19, 2024 to Dec 22, 2024v28
  3. Minor Start date: Dec 18, 2024 to Dec 19, 2024 Eligibility criteria expanded, about 7 wordsv27 Show 1 more changeShow less
    • Eligibility criteria expanded, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  4. Minor Start date: Dec 17, 2024 to Dec 18, 2024v26
  5. Minor Start date: Dec 9, 2024 to Dec 17, 2024v25
  6. Notable Trial status: Not Yet Recruiting to Recruiting Site details revisedv24 Show 1 more changeShow less
    • Site details revised
  7. Minor Start date: Dec 8, 2024 to Dec 9, 2024v23
  8. Minor Start date: Dec 5, 2024 to Dec 8, 2024v22
  9. Minor Start date: Dec 2, 2024 to Dec 5, 2024v21
  10. Minor Start date: Dec 1, 2024 to Dec 2, 2024v20
  11. Minor Start date: Nov 28, 2024 to Dec 1, 2024v19
  12. Minor Start date: Nov 26, 2024 to Nov 28, 2024v18
  13. Minor Start date: Nov 25, 2024 to Nov 26, 2024v17
  14. Minor Start date: Nov 24, 2024 to Nov 25, 2024v16
  15. Minor Start date: Nov 21, 2024 to Nov 24, 2024v15
  16. Minor Start date: Nov 20, 2024 to Nov 21, 2024v14
  17. Minor Start date: Nov 19, 2024 to Nov 20, 2024v13
  18. Minor Start date: Nov 18, 2024 to Nov 19, 2024v12
  19. Minor Start date: Nov 17, 2024 to Nov 18, 2024v11
  20. Minor Start date: Nov 14, 2024 to Nov 17, 2024v10
  21. Minor Start date: Nov 13, 2024 to Nov 14, 2024v9
  22. Minor Start date: Nov 12, 2024 to Nov 13, 2024v8
  23. Minor Start date: Nov 11, 2024 to Nov 12, 2024v7
  24. Minor Start date: Nov 10, 2024 to Nov 11, 2024v6
  25. Minor Start date: Nov 7, 2024 to Nov 10, 2024v5
  26. Minor Start date: Nov 5, 2024 to Nov 7, 2024v4
  27. Minor 2 versions Re-verified since Oct 10, 2024, no change to tracked fieldsv2-v3
  1. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Background: Cushing syndrome (CS) is a set of diseases that develop when the body produces too much adrenocorticotropic hormone (ACTH). ACTH stimulates the production of a hormone called cortisol. Excess cortisol can cause serious issues, such as diabetes, high blood pressure, weight gain, and mood changes. Diagnosing CS early can be difficult. One test used to diagnose CS, the desmopressin (Desmo) stimulation test (DesmoST), has not been studied in enough people to know how accurate it is. Objective: To find ways to improve the DesmoST. Researchers especially want to learn more about how well the DesmoST identifies people with specific ACTH CSs: Cushing disease (CD) and ectopic ACTH syndrome (EAS). Eligibility: People aged 18 to 70 years who have or may have CS, especially CD or EAS. Healthy volunteers are also needed. Design: Participants with CS will have 3 DesmoSTs at least 48 hours apart. The procedure for each is as follows: They will limit their fluid intake the day before each test. They will have nothing to eat or drink for 12 hours before the test. For 1 of the tests, they will take a pill that contains a hormone (dexamethasone). They will take it around 11 pm the day before the test. Desmo is given through a tube attached to a needle inserted into a vein. Blood will be drawn a total of 6 times before and after the desmo is given. Healthy volunteers will have 4 DesmoSTs. These will be 2 to 14 days apart. All participants will have follow-up visits 3 to 5 days after each test. These visits may be by phone.
Trial Details
NCT Number NCT06635629
Lead Sponsor National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Conditions Cushing Syndrome
Enrollment 140 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov